XML 61 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income (Loss) Before Income Taxes
For financial reporting purposes, income before income taxes includes the following components:

Years Ended December 31,
(in millions)202320222021
United States$36.4 $8.5 $12.8 
Foreign6.4 (4.1)1.0 
Income before income taxes$42.8 $4.4 $13.8 
Provision (Benefit) for Income Tax
The provision (benefit) for income taxes consists of the following:

Years Ended December 31,
(in millions)202320222021
Current provision (benefit):
Federal$8.2 $17.4 $(0.4)
State4.5 2.4 (0.7)
Foreign2.8 2.3 0.3 
Total current provision (benefit)
15.5 22.1 (0.8)
Deferred benefit:
Federal(3.6)(18.3)(0.1)
State(2.8)(1.0)1.1 
Foreign— 2.2 (2.3)
Total deferred benefit
(6.4)(17.1)(1.3)
Total provision (benefit):
Federal4.6 (0.9)(0.5)
State1.7 1.4 0.4 
Foreign2.8 4.5 (2.0)
Total income tax provision (benefit)
$9.1 $5.0 $(2.1)
Reconciliation of Provision for Income Taxes at Statutory Federal Income Tax Rate A reconciliation of the provision (benefit) for income taxes at the statutory federal income tax rate to the amount provided is as follows:
Years Ended December 31,
(in millions)202320222021
Tax expense at the statutory federal income tax rate$8.9 $0.9 $2.9 
State income tax, net of federal income tax0.4 0.6 1.3 
Research and development tax credits(2.8)(3.3)(4.1)
Impact of uncertain tax positions1.0 1.2 1.8 
Impact of uncertain tax positions - liquidation of subsidiary— — (0.7)
Change in foreign subsidiary net operating loss carryforward— — 4.4 
Valuation allowance impact0.3 6.0 (8.1)
Changes in tax rates0.8 0.2 0.7 
Share-based compensation0.6 0.4 0.4 
Foreign-derived intangible income deduction(0.7)(0.9)— 
Foreign tax credit(0.5)(0.2)— 
Other items1.1 0.1 (0.7)
Total income tax provision (benefit)$9.1 $5.0 $(2.1)
Significant Components of Company's Deferred Tax Assets and Liabilities
Significant components of the Company's deferred tax assets and liabilities are as follows:

December 31,
(in millions)20232022
Deferred tax assets:
Amortization of research and experimental expenditures$24.7 $18.4 
Inventory reserves5.8 4.7 
Warranty reserves3.7 2.2 
Credit loss reserves0.8 0.6 
State tax loss carryforwards11.5 11.6 
Accrued vacation1.2 1.6 
Deferred compensation1.1 1.1 
Share-based compensation2.6 4.4 
Goodwill1.7 1.8 
Foreign net operating loss7.9 7.2 
Lease obligation1.3 1.8 
Employee & insurance accruals1.0 1.0 
Domestic credit carryforwards1.5 1.5 
Deferred revenue2.2 1.7 
Valuation allowances(12.5)(11.9)
Other— 0.9 
Total deferred tax assets54.5 48.6 
Deferred tax liabilities:
Property and equipment14.0 13.6 
Intangibles1.8 2.7 
Right-of-use assets1.3 1.8 
Post-retirement benefits0.5 0.5 
Other0.5 — 
Total deferred tax liabilities18.1 18.6 
Total net deferred assets$36.4 $30.0 
Rollforward of Deferred Tax Assets Valuation Allowance
The following table represents a rollforward of the deferred tax asset valuation allowance for the years ended December 31, 2023, 2022 and 2021:

Years Ended December 31,
(in millions)202320222021
Allowance balance, beginning of year$11.9 $5.9 $14.0 
Provision1.8 6.0 0.6 
Reversals(1.6)— (8.1)
Other0.4 — (0.6)
Allowance balance, end of year$12.5 $11.9 $5.9 
Reconciliation of Unrecognized Tax Benefit
A reconciliation of the beginning and ending unrecognized tax benefits excluding interest and penalties is as follows:

Years Ended December 31,
(in millions)202320222021
Balance, beginning of year$12.0 $10.8 $9.7 
Additions for tax positions taken in current year0.9 1.2 1.0 
Additions for tax positions taken in prior period0.1 — 0.8 
Decreases related to sustained tax positions— — (0.7)
Balance, end of year$13.0 $12.0 $10.8